FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1989061029> ?p ?o ?g. }

• W1989061029 abstract "Background: Recent FDA approval of B-Raf and Mek inhibitors has improved treatment outcomes for patients with BRAFV600E/K metastatic melanoma. However, most patients receiving these agents progress within a year and are left with limited treatment options. Few validated screening tools exist to evaluate potentially beneficial therapies for these resistant/refractory patients. To address this deficiency we have established patient-derived xenograft (PDX) model sets by collecting serial samples at timepoints when patients demonstrated sensitivity and resistance to B-Raf and Mek inhibitors and characterized each by mutation, receptor and ligand density and drug sensitivity.Methods: Paired, sensitive/insensitive PDX melanoma models from three patients were established in athymic nude mice from primary or metastatic patient tissue. Baseline samples for each paired model were collected from patients who subsequently reported clinical response to a therapy and again once the patient progressed on that therapy. Established models were confirmed by histologic comparative analysis and linked with patient treatment and outcome data. For each model DNA was extracted and subjected to exon sequencing of 207 known oncogenes; growth factor receptor and ligand densities were interrogated using immunohistochemistry and quantitative RNA in situ hybridization. Drug sensitivity studies were performed evaluating and comparing each model following treatment with oral vemurafenib, trametinib or dabrafenib. Study endpoints included tumor volume and time from treatment initiation, with tumor growth inhibition, delay and regression reported at study completion.Results: The B-RafV600E models ST052, ST052B, ST052C and ST052D reported sensitivity or resistance to vemurafenib correlative with clinical response and progression. Trametinib but not vemurafenib was active towards the ST361 B-RafV600R model while the ST361B model was found insensitive to both agents. Trametinib sensitivity to the ST697 and ST697B H-RasQ61K models was correlative with clinical response and progression. Dabrafenib sensitivity was similar to vemurafenib in evaluated models. Expression of HER3, a mechanism of possible adaptive resistance to targeted therapies, but not EGFR or HER2 was reported in all models and was relatively unchanged in serial models sets; heregulin expression was also determined in each model.Conclusion: We have established patient-derived xenograft (PDX) model sets with sensitivity and resistance to B-Raf and Mek inhibitors correlative with clinical response and progression. Receptor and ligand expression was identified and maintained in serial models. Based on these results this panel can serve as a valuable screening tool to evaluate potentially beneficial therapies for patients resistant/refractory to B-Raf and Mek inhibitors.Citation Information: Mol Cancer Ther 2013;12(11 Suppl):C10.Citation Format: Michael J. Wick, Justin Meade, Jennifer Brown, Teresa L. Vaught, Anthony W. Tolcher, Lizette Gamez, Drew Rasco, Amita Patnaik, Ronald Drengler, Kyriakos P. Papadopoulos. Establishment and characterization of melanoma patient-derived xenograft (PDX) model sets: correlation with clinical response and progression using serial biopsy sampling. [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; 2013 Oct 19-23; Boston, MA. Philadelphia (PA): AACR; Mol Cancer Ther 2013;12(11 Suppl):Abstract nr C10." @default.
• W1989061029 created "2016-06-24" @default.
• W1989061029 creator A5001759866 @default.
• W1989061029 creator A5003086828 @default.
• W1989061029 creator A5007242816 @default.
• W1989061029 creator A5016675333 @default.
• W1989061029 creator A5022467575 @default.
• W1989061029 creator A5024107490 @default.
• W1989061029 creator A5036071372 @default.
• W1989061029 creator A5060992997 @default.
• W1989061029 creator A5070570779 @default.
• W1989061029 creator A5073134832 @default.
• W1989061029 date "2013-11-01" @default.
• W1989061029 modified "2023-09-25" @default.
• W1989061029 title "Abstract C10: Establishment and characterization of melanoma patient-derived xenograft (PDX) model sets: correlation with clinical response and progression using serial biopsy sampling." @default.
• W1989061029 doi "https://doi.org/10.1158/1535-7163.targ-13-c10" @default.
• W1989061029 hasPublicationYear "2013" @default.
• W1989061029 type Work @default.
• W1989061029 sameAs 1989061029 @default.
• W1989061029 citedByCount "0" @default.
• W1989061029 crossrefType "proceedings-article" @default.
• W1989061029 hasAuthorship W1989061029A5001759866 @default.
• W1989061029 hasAuthorship W1989061029A5003086828 @default.
• W1989061029 hasAuthorship W1989061029A5007242816 @default.
• W1989061029 hasAuthorship W1989061029A5016675333 @default.
• W1989061029 hasAuthorship W1989061029A5022467575 @default.
• W1989061029 hasAuthorship W1989061029A5024107490 @default.
• W1989061029 hasAuthorship W1989061029A5036071372 @default.
• W1989061029 hasAuthorship W1989061029A5060992997 @default.
• W1989061029 hasAuthorship W1989061029A5070570779 @default.
• W1989061029 hasAuthorship W1989061029A5073134832 @default.
• W1989061029 hasConcept C114851261 @default.
• W1989061029 hasConcept C126322002 @default.
• W1989061029 hasConcept C142724271 @default.
• W1989061029 hasConcept C143998085 @default.
• W1989061029 hasConcept C184235292 @default.
• W1989061029 hasConcept C204232928 @default.
• W1989061029 hasConcept C2775934546 @default.
• W1989061029 hasConcept C2776131300 @default.
• W1989061029 hasConcept C2777658100 @default.
• W1989061029 hasConcept C2778472372 @default.
• W1989061029 hasConcept C2778830669 @default.
• W1989061029 hasConcept C2781249067 @default.
• W1989061029 hasConcept C2994587330 @default.
• W1989061029 hasConcept C502942594 @default.
• W1989061029 hasConcept C57074206 @default.
• W1989061029 hasConcept C71924100 @default.
• W1989061029 hasConcept C86803240 @default.
• W1989061029 hasConcept C89423630 @default.
• W1989061029 hasConcept C95444343 @default.
• W1989061029 hasConceptScore W1989061029C114851261 @default.
• W1989061029 hasConceptScore W1989061029C126322002 @default.
• W1989061029 hasConceptScore W1989061029C142724271 @default.
• W1989061029 hasConceptScore W1989061029C143998085 @default.
• W1989061029 hasConceptScore W1989061029C184235292 @default.
• W1989061029 hasConceptScore W1989061029C204232928 @default.
• W1989061029 hasConceptScore W1989061029C2775934546 @default.
• W1989061029 hasConceptScore W1989061029C2776131300 @default.
• W1989061029 hasConceptScore W1989061029C2777658100 @default.
• W1989061029 hasConceptScore W1989061029C2778472372 @default.
• W1989061029 hasConceptScore W1989061029C2778830669 @default.
• W1989061029 hasConceptScore W1989061029C2781249067 @default.
• W1989061029 hasConceptScore W1989061029C2994587330 @default.
• W1989061029 hasConceptScore W1989061029C502942594 @default.
• W1989061029 hasConceptScore W1989061029C57074206 @default.
• W1989061029 hasConceptScore W1989061029C71924100 @default.
• W1989061029 hasConceptScore W1989061029C86803240 @default.
• W1989061029 hasConceptScore W1989061029C89423630 @default.
• W1989061029 hasConceptScore W1989061029C95444343 @default.
• W1989061029 hasLocation W19890610291 @default.
• W1989061029 hasOpenAccess W1989061029 @default.
• W1989061029 hasPrimaryLocation W19890610291 @default.
• W1989061029 hasRelatedWork W1966006491 @default.
• W1989061029 hasRelatedWork W2033888421 @default.
• W1989061029 hasRelatedWork W2056478112 @default.
• W1989061029 hasRelatedWork W2087836455 @default.
• W1989061029 hasRelatedWork W2092424194 @default.
• W1989061029 hasRelatedWork W2315517369 @default.
• W1989061029 hasRelatedWork W2317639701 @default.
• W1989061029 hasRelatedWork W2346903055 @default.
• W1989061029 hasRelatedWork W2400149688 @default.
• W1989061029 hasRelatedWork W2406042859 @default.
• W1989061029 hasRelatedWork W2493930640 @default.
• W1989061029 hasRelatedWork W2565605759 @default.
• W1989061029 hasRelatedWork W2565914818 @default.
• W1989061029 hasRelatedWork W2775354429 @default.
• W1989061029 hasRelatedWork W2885804495 @default.
• W1989061029 hasRelatedWork W2887166320 @default.
• W1989061029 hasRelatedWork W2940964174 @default.
• W1989061029 hasRelatedWork W2993586750 @default.
• W1989061029 hasRelatedWork W3033654873 @default.
• W1989061029 hasRelatedWork W3083351885 @default.
• W1989061029 isParatext "false" @default.
• W1989061029 isRetracted "false" @default.
• W1989061029 magId "1989061029" @default.
• W1989061029 workType "article" @default.